Past Events

Shaping the Management of Parkinson's Disease

Aired on 1.23.2021
FREE
Shaping the Management of Parkinson's Disease CME

 8th Annual Shaping the Management of Parkinson's Disease:

Debating Current Controversies and Discussing Recent Advances

 

January 23, 2021, 8:30 am - 4:00 pm EST

January 24, 2021, 8:30 am - 12:30 pm EST

 

Description

Innovations and advances in the field of PD — including evaluation, treatment, and prevention — continue to occur at a rapid pace, challenging both specialists and generalists to stay abreast of the changes, creating gaps in knowledge, competence, and practice among health care providers. In many cases, the data are not clear regarding the clinical implications. In turn, this creates a pressing need for educational activities focused on providing updates and critical analyses of both the pros and cons of the most recent advances in the care of patients with PD.

This educational activity is intended for neurologists, neurosurgeons, nurse practitioners, nurses, physician assistants, residents, fellows and other health care professionals who treat patients with Parkinson’s Disease.


Directors & Faculty

Directors

Hubert Fernandez, MD

PSG Executive Committee Co-Chair& Credentialing Committee Chair

Michael Schwarzschild, MD, PhD

PSG Executive Committee Chair


Additional Faculty

Roy Alcalay, MD, MS

PSG Genetics & Environmental Risk Factors Working Group Co-Chair,  PSG Mentoring Committee Member

Helen Bronte-Stewart, MD, MS

Susan Fox, MRCP, PhD

Joohi Jimenez-Shahed, MD

PSG Functional Neurosurgical Working Group Chair

Peter Lewitt, MD

Zoltan Mari, MD

Aristide Merola, MD, PhD

Tiago Mestre, MD, MSc

Martha Nance, MD

PSG Genetics & Environmental Risk Factors Working Group Chair

Fernando Pagan, MD

Gregory Pontone, MD

PSG Scientific Review Committee Member &  PSG Cogntive/Psychiatric (Behavior) Working Group Chair

Liana Rosenthal, MD, PhD

Marie Saint-Hilaire, MD, MRCP(C), FAAN

Andrew Siderowf, MD, MSCE

Tanya Simuni, MD

PSG Executive Committee Member

Allison Willis, MD, MS

Anne-Marie Wills, MD, MPH

Michele York, PhD, ABPP-CN

Agenda

Objectives

After completing this activity, the participant will be able to do the following:

  • List the most recent insights from studies investigating the role of genetic targets in disease- modifying therapies for Parkinson disease.
  • Discuss how COVID-19 has promoted telemedicine for follow-up care of patients with Parkinson disease as well as its impact on clinical trial design.
  • Summarize the evidence supporting the efficacy of behavioral and nonmotor therapies for Parkinson disease.
  • Critically assess the outcomes and issues when comparing closed-loop technology against directional leads for deep brain stimulation.
  • Describe the available neuropsychological tests for detecting mild cognitive impairment in Parkinson disease and discuss the best timing of their use.
  • List the options for short-acting rescue therapies in Parkinson disease and their potential use as on-demand therapy.
  • Discuss the accuracy of the scale for measuring motor fluctuations in Parkinson disease in relation to its use as an outcome measure in symptomatic trials.

Disclosures and Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The Cleveland Clinic Foundation Center for Continuing Education and Parkinson Study Group. The Cleveland Clinic Foundation Center for Continuing Education is accredited by the ACCME to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this internet live activity for a maximum of 9.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

For the purposes of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME.

Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition.  The viewpoints expressed in this CME activity are those of the authors/faculty.  They do not represent an endorsement by The Cleveland Clinic Foundation.  In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

Copyright © 2021 The Cleveland Clinic Foundation.  All Rights Reserved.

Show Disclosure